Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Bone Marrow Failure Disorders × Alemtuzumab × 1 year × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Transplantation 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Adenocarcinoma, Clear Cell 1

Interventions

fludarabine phosphate 3 fludarabine 3 Antilymphocyte Serum 3 Whole-Body Irradiation 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Cyclophosphamide 2 treosulfan 1 thymoglobulin 1 X-Rays 1 Tacrolimus 1 Specimen Handling 1 Sirolimus 1 Passive Cutaneous Anaphylaxis 1 Morphine 1 Methotrexate 1 Methadone 1 Hydromorphone 1 Genetic Counseling 1 Emapalumab 1 Cyclosporins 1 Clofarabine 1 Clinical Trials, Phase I as Topic 1 Busulfan 1 Bone Marrow Transplantation 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡